Comparative transcriptomic analysis of hepatocellular carcinoma according to primary liver disease using TCGA-LIHC data

Authors

  • Ana Maria Ciurdorean 3rd Department of Surgery, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Genomics, MEDFUTURE Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
  • Paul Chiroi Department of Genomics, MEDFUTURE Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania https://orcid.org/0000-0002-7019-1426 (unauthenticated)
  • Cristina Ciocan Department of Genomics, MEDFUTURE Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
  • Alexandra Trif Department of Genomics, MEDFUTURE Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
  • Stefan Strilciuc Department of Genomics, MEDFUTURE Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
  • Daniel Gabriel Cosma Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
  • Ioana Rusu Department of Pathology, Octavian Fodor Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romania
  • Ioana Berindan-Neagoe Department of Genomics, MEDFUTURE Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Doctoral School, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Romanian Academy of Medical Sciences, Biomedical Sciences, Bucharest, Romania https://orcid.org/0000-0001-5828-1325 (unauthenticated)
  • Nadim Al Hajjar 3rd Department of Surgery, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Surgery, Octavian Fodor Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romania

DOI:

https://doi.org/10.15386/mpr-3024

Keywords:

transcriptome, gene expression profiling, RNA, long noncoding, computational biology, carcinoma, hepatocellular

Abstract

Background and aim: Hepatocellular carcinoma arises in heterogeneous chronic liver conditions, including hepatitis B virus and hepatitis C virus infection, alcohol-associated liver disease, cirrhosis, and hepatic steatosis. The extent to which the tumor transcriptome reflects the underlying liver disease remains incompletely defined.

Methods: We analyzed publicly available data from The Cancer Genome Atlas Liver Hepatocellular

Carcinoma cohort by clinical background, comparing hepatitis C virus-associated and hepatitis B virus-associated tumors with their respective adjacent non-tumor tissue, viral hepatitis-associated with alcohol-associated tumors, and tumors arising with viral hepatitis, alcohol use, or cirrhosis versus steatosis-associated tumors. Differential expression was assessed using an unpaired t-test with Benjamini-Hochberg correction and a fold-change threshold of 1.5.

Results: Hepatitis C virus-associated tumors showed 451 differentially expressed genes versus adjacent non-tumor tissue (61 upregulated, 390 downregulated); hepatitis B virus-associated tumors showed 500 (143 upregulated, 357 downregulated). Of these, 269 were shared and all were concordantly regulated, the most strongly downregulated corresponding to liver sinusoidal endothelial cell markers. Viral hepatitis-associated and alcohol-associated tumors differed by only three genes. Comparisons involving steatosis-associated tumors revealed broader differences (107 to 233 genes) dominated by cytochrome P450, drug, and retinol metabolism; however, that subgroup comprised only 12 tumors, and these findings are exploratory. Ten differentially expressed non-coding transcripts, comprising nine long non-coding ribonucleic acids and one pseudogene, were shared between the hepatitis B virus and hepatitis C virus comparisons. By contrast, the non-coding transcripts shared across the steatosis comparisons were sex-chromosome-linked, could not be distinguished from an effect of sex composition, and were not interpreted further.

Conclusion: Hepatitis B virus-associated and hepatitis C virus-associated tumors therefore share a substantial, concordant transcriptional program despite differing viral etiologies, whereas differences associated with the underlying liver disease are concentrated in hepatic metabolic and xenobiotic-processing

Downloads

Published

2026-09-23

Issue

Section

Original Research

How to Cite

1.
Comparative transcriptomic analysis of hepatocellular carcinoma according to primary liver disease using TCGA-LIHC data. Med Pharm Rep [Internet]. 2026 Sep. 23 [cited 2026 Nov. 19]; Available from: https://medpharmareports.com/index.php/mpr/article/view/3024